June 10, 2024· 47 min

This Is How the Food Industry Is Preparing For a Post-Ozempic World

Orality
Model
69%
Oral-dominant (speeches, podcasts, storytelling)

Speaker Breakdown

HostTracy Alloway(1,877 words)
M:29%
HostJoe Weisenthal(1,579 words)
M:94%
GuestBarb Stuckey(4,058 words)
M:27%

Oral Indicators

Agonistic32%
literally, completely, crazy
Engagement76%
you, our, your
Memory Aids100%
listen, now, like
Repetition100%
like (105x), know (65x), really (47x)
Parallelism100%
And I'm Tracy Alloway...., And, you know, it's kinda just..., But I actually think that, lik...
Sound Patterns44%
37 question(s), alliteration: "markets move", alliteration: "barclays brief"
Formulaic Phrases5%
you know what, i mean

Literate Indicators

Hedging6%
could, maybe, seemingly
Passive Voice2%
be worried, are grilled, is layered
Abstract Nouns16%
investment, recommendation, proliferation
Subordination6%
because, though, unless
Sentence Length34%
Avg: 13.5 words/sentence
Word Complexity46%
investment, analyze, anticipate
Academic Markers0%
Impersonal Style24%
635 personal pronouns found
Descriptive Style88%
literally, completely, actually

Description

The rise of GLP-1 drugs, like Ozempic, is a potentially existential threat to the makers of salty, sugary, high-calorie snack foods. But it's obvious that the gigantic food industry will search out ways to adapt. So what types of new products will they sell? How will they be flavored? How will they be packaged and marketed? On this episode of the podcast, we speak with Barb Stuckey. She is the chief innovation and marketing officer at Mattson, a San Francisco Bay Area company that helps food producers find the next big flavor. Her team recently undertook a big study of Ozempic users to get a better understanding of how it changed their diets. She speaks to us about what they learned, what new types of products are in development, and how food manufacturers find the next big thing. See omnystudio.com/listener for privacy information.